March 1996
Volume 37, Issue 4
Free
Articles  |   March 1996
Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
Author Affiliations
  • P K Rabiah
    Department of Ophthalmology and Visual Science, University of Illinois at Chicago, USA.
  • R G Fiscella
    Department of Ophthalmology and Visual Science, University of Illinois at Chicago, USA.
  • H H Tessler
    Department of Ophthalmology and Visual Science, University of Illinois at Chicago, USA.
Investigative Ophthalmology & Visual Science March 1996, Vol.37, 613-618. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P K Rabiah, R G Fiscella, H H Tessler; Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.. Invest. Ophthalmol. Vis. Sci. 1996;37(4):613-618.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: To determine in rabbits whether periocular injection of ketorolac tromethamine effectively delivers the drug to the eye and, if so, whether this is efficacious in the treatment of experimental uveitis. METHODS: Ketorolac was administered by anterior subconjunctival injection, posterior periocular injection, intramuscular injection, or topical eye drops. The aqueous and vitreous were assayed for ketorolac. Anterior subconjunctival and topical ketorolac were compared to control as well as topical and anterior subconjunctival steroid treatments in uveitis induced by the intravitreal injection of tumor necrosis factor. RESULTS: Anterior subconjunctival injection led to high, though short-lived, levels of drug in the aqueous and vitreous. Posterior periocular injection led to much lower levels. Topical dosing led to relatively low aqueous and undetectable vitreous levels. No ocular levels were detected after intramuscular dosing. All tested antiinflammatory treatments were similarly effective in controlling uveitis. CONCLUSIONS: Anterior subconjunctival injection of ketorolac produced high intraocular concentrations of drug and was beneficial in controlling the inflammation in this animal model of uveitis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×